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Abstract.  The selectins are a family of three calcium- 
dependent lectins that mediate adhesive interactions 
between leukocytes and the endothelium during nor- 
mal and abnormal inflammatory episodes. Previous 
work has implicated the carbohydrate sialyl Lewis  x 
(sLex;  sialic acid alpha 2-3 galactose beta 1-4 [Fucose 
alpha  1-3] N-acetyl glucosamine) as a component of 
the ligand recognized by E- and P-selectin.  In the case 
of P-selectin,  other components of the cell surface,  in- 
cluding 2'6-1inked sialic acid and sulfatide (galactose- 
4-sulfate ceramide),  have also been proposed for ad- 
hesion mediated by this selectin.  We have recently 
defined a region of the E-selectin lectin domain that 
appears to be directly involved with carbohydrate rec- 
ognition and cell adhesion (Erbe, D. V,, B. A. Wolitzky, 
L.  G.  Presta,  C.  R. Norton,  R. J.  Ramos, D. K. 
Bums, R. M.  Rumberger, B.  N. N.  Rao, C.  Foxall, 
B. K.  Brandley, and L. A. Lasky.  1992. J.  Cell Biol. 
119:215-227).  Here we describe a  similar analysis of 
the P-selectin lectin domain which demonstrates that a 
homologous region of this glycoprotein's lectin motif is 
involved with carbohydrate recognition and cell bind- 
ing.  In addition,  we present evidence that is inconsis- 
tent with a biological role for either 2 '6-1inked  sialic 
acid or sulfatide in P-selectin-mediated adhesion. 
These results suggest that a common region of the 
E- and P-selectin tectin domains appears to mediate 
carbohydrate recognition and cell adhesion. 
p 
-  and  E-selectin are calcium-dependent  cell surface 
lectins that mediate leukocyte adhesion by recognition 
of cell-specific  carbohydrate ligands.  Together  with 
L-selectin, they form a  family of cell adhesion molecules 
(24, 25) that contain lectin,  epidermal growth factor (EGF)- 
like, and complement binding-like  domains  (4,  18, 28, 36, 
39). L-selectin is found on all leukocytes and appears to rec- 
ognize an unknown  sialylated,  fucosylated, sulfated carbo- 
hydrate ligand on at least two endothelial  glycoproteins  (17, 
42). One of these glycoproteins,  which has been named Gly- 
CAM 1, is a mucin-like endothelial glycoprotein that appears 
to present carbohydrate ligands to the L-selectin lectin do- 
main (27).  E-selectin is an endothelial  adhesion  molecule 
whose expression is induced by various inflammatory  stim- 
uli and which recognizes the cell surface carbohydrate,  sialyl 
Lewis x  (sLex~; sialic  acid  alpha  2-3  galactose beta  1-4 
[fucose alpha  1-3] N-acetyl glucosamine)  (29, 33, 40, 45). 
P-selectin  is found stored in alpha  granules  of platelets  as 
well as Weible-Palade bodies of endothelial  cells (5, 30). It 
appears to recognize a carbohydrate that is either identical, 
or closely related, to sLe  x (22, 23, 31, 34) in the context of 
perhaps a single glycoprotein (31, 32, 37). 
1. Abbreviations used in thispaper: Fc-/R, IgG Fc receptors; MBP, mannose 
binding protein; sLe  x, sialyl Lewis x. 
Much evidence has accumulated to indicate similarities in 
the nature of the carbohydrates seen by selectins. Sialylated, 
fucosylated lactosaminoglycans  (such as  sLe0 have  been 
shown to bind L-, E-, and P- selectin (12, 16, 29, 33, 34, 40, 
45, 49). Furthermore, all three selectins require both sialic 
acid and fucose residues in specific linkages for adhesion (7, 
8, 38, 43). However, the exact carbohydrate structures recog- 
nized by selectins are currently incompletely characterized. 
In addition,  many studies  have demonstrated clear differ- 
ences in carbohydrate recognition by selectins. For example, 
in contrast to E-selectin,  both L- and P-selectin  have been 
shown  to bind sulfatide  (galactose-4-sulfate  ceramide) (1, 
12).  Another distinction  in selectin-carbohydrate interac- 
tions  emerged in a recent study by Larsen and colleagues 
(24) in which the Sambucus nigra lectin,  which is specific 
for the sialyl-2'6BGal/GalNAc  linkage,  blocked P-selectin 
binding but not E-selectin binding. This led these authors to 
propose that the carbohydrate recognized by P-selectin con- 
tains  a  terminal  2'3  sLe  x core  plus  a  second,  perhaps 
branched  terminal  sialic  acid  linked  2'6  to  a  galactose, 
whereas the carbohydrate recognized  by E-selectin  may be 
simply 2'3 sLe  ~ (24).  In fact, P-selectln is the only selectin 
that binds to the 2'6 form of an sLe  ￿9 glycolipid immobilized 
on microtitre wells, although this binding  is weak and vari- 
able (12). Thus, evidence exists for the possible participation 
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ificity in P-selectin binding to its ligand. Specificity in selec- 
tin-carbohydrate interactions may stem from other varia- 
tions on this common carbohydrate (i.e., sLe~-like) theme, 
such as the addition of sulfate for the L-selectin ligand (Imai, 
Y.,  L. A.  Lasky, and S.  Rosen, manuscript submitted for 
publication). Additionally, specificity may stem from varia- 
tions in carbohydrate presentation (44).  For instance, spe- 
cific glycoproteins appear to present the L- and P-selectin 
cognate carbohydrate ligands whereas E-selectin appears to 
recognize a glycolipid (or a protease-resistant glycoprotein) 
(28,  32). 
Because of these differences in carbohydrate recognition 
within the context of structural similarities, it seems reason- 
able to suppose that the highly homologous lectin domains 
of selectins may use a common recognition site for sugars, 
with some interspersed amino acid variation that confers 
specificity. Previously, we used a combination of mutagene- 
sis and modeling to identify a discontinuous region of the 
E-selectin lectin domain that appears to form at least part of 
its binding site for 2'3  sLe  x (10). This study modeled the 
E-selectin lectin domain using the crystal structure of the 
mannose binding protein (47) as a guide and demonstrated 
the importance of residues within a patch, formed by the an- 
tiparallel beta sheet derived from the amino and carboxy ter- 
mini and two adjacent loops, in the binding of both blocking 
anti-E-selectin mAbs, and in the binding of sLe  ￿9 itself (10). 
Additionally, the relatively small size of  the E-selectin region 
identified as critical for ligand recognition was consistent 
with nuclear magnetic resonance solution analyses of 2'3 
sLe  ~ structure showing that the critical sialic acid and fu- 
cose residues point to one face of this carbohydrate and are 
separated by ~10 A (2, 43). 
In this study we extend understanding of selectin structure 
and function by demonstrating that the site identified as im- 
portant for E-selectin binding also serves an important role 
in P-selectin binding. Mutagenesis of this site in P-selectin 
also provides clues to some of the structural basis for the 
similarities and differences in carbohydrate recognition by 
selectins. 
Materials and Methods 
Flow Cytometric Assay for P-selectin Ligand 
The interaction of P-selectin and its cellular ligand was studied using a flow 
cytometric assay. Cells used in this assay were either HL60 cells (main- 
tained in high glucose DME plus 10% Hyclone FBS) or fresh human neu- 
trophils.  Human neutrophils were purified  from heparinized peripheral 
blood by a Ficoil-Hypaque  gradient to remove mononuclear cells, followed 
by treatment with 3 % dextran sulfate to remove red blood cells. The result- 
ing cells were 2>90% nentrophils.  Before staining with P-selectin-IgG  both 
cell types were preincubated in Dulbecco's  PBSFI% BSA/0,1%  sodium 
azide/l% normal rabbit serum (staining medium) for 30-60 rains on ice. 
After this initiai incubation, 1/tg of P-selectin-IgG was added to 100-/~l  ali- 
qnots of 106 cells and incubated for 30-60 rains on ice. The ceils were then 
washed  with staining medium and resuspended in  100  /~l of staining 
medium to which was added 2/~l of a phycoerythrin-conjugnted  F(at02 
goat anti-human  IgG (Fc specific). The ceils were incubated for 15-30 rains 
on ice, washed twice with staining medium, and resuspended in 0.5 ml of 
staining medium before flow cytometric analysis  on a FACScan (Becton 
Dickinson & Co., Mountain View, CA). To determine that the staining was 
an interaction of P-selectin with its ligand, the staining was also done in the 
presence of l0 mM EGTA.  To determine the protease sensitivity and the 
requirement for sialic acid of this interaction, HL-60 cells in D-PBS and 
1% BSA were incubated with either trypsin or Arthrohacter or Clostridium 
sialidases  at 37~  before resuspending  in stainlnS medium. To determine 
the effect of activation on the expression of the ligand,  human neutrophils 
were incubated at 37~  with 50 ng/ml phorbot myristate acetate for 10 vain 
before resuspending  in staining medium. To examine the ability of various 
carbohydrates to inhibit staining, 50 ~g/ml fucoidin (Sigma Immunochemi- 
cals, St. Louis, MO), 50 ~g/ml dextran sulfate (Pharmncia Fine Chemicals, 
Piscataway,  NJ),  I0 mg/ml mannose-l-phosphate (Sigma  Imrnunochemi- 
cals), or 10 mg/ml mannose-6-phosphate  (Sigma Immunochemicals) was 
added to cells immediately before the addition of the P-selectin  chimera. 
Each carbohydrate  was then present until the cells were washed before the 
addition of  the second stage antibody. A potential complication of this FACS 
assay arose from the use of selectin-IgG chimeras to stain cells (HL60 cells 
and neutrophils)  which bear human IgG Fc receptors (Fc3,R; see reference 
11 for review). Adding rabbit IgG (in the form of normal rabbit serum) to 
the assay medium blocked this binding in most cases. However, in some ex- 
periments with human neutrop~s, it was necessary  to add murine mAbs 
to human FcTR (Medarex, Inc., West Lebanon, NH) to the assay medium 
to completely  block this interaction. 
Anti-selectin mAbs 
The following anti-human P-seleetin mAbs were purchased to characterize 
the mutant chimeras: mAbs AK-6 (CLB-thromb/6) and CRC 81 from Bio- 
Design International (Kennebunkport,  ME), and mAb AC 1.2 from Beeton 
Dickinson & Co. The anti-E-selectin mAbs 9AI, 7El0, 3B7, and 9tt9 have 
been described (10). The anti-L-seleetin mAb Leu 8 was purchased from 
Becton Dickinson & Co. and used in the FACS assay (a registered trademark 
of Becton Dickinson & Co.) according to the manufacturer's  instructions. 
Construction and Expression of gqld 
and Mutant Chimeras 
Production and characterization of the P- and E-selectin-IgG chimeras has 
been previously described (12). The PE-I chimera was constructed in tw~ 
steps.  First, an EcoRI-Xhol fragment encoding the signal peptide, lectin 
domain, and part of the EGF domain of P-selectin was removed from a 
pRKSIP-seleetin-IgG  plasmid. This fragment was inserted into a pRK5/ 
E-selectin-lgG  plasmid which had been  digested with EcoRI and BgilI to re- 
move the E-selectin signal peptide and most of  the E-seleetin leetin domain. 
Second, the P-selectin lectin domain was joined in frame to the E-seleetin 
EGF domain via oligonucleetide-direeted  deletional mutagenesis using the 
method of Kunkel (21) as described 00). The expressed PE-1 construct con- 
sisted of the signal peptide and lectin domain from P-selectin,  followed by 
the EGF, CR1 and CR2 domains of E-selectin,  and the IgG1 hinge, CH2 
and CH3 domains common to both the P-seleetin-IgG  and E-seleetin-IgG 
constructs. 
Amino acid substitutions  were introduced into the lectin domain of the 
P-selectin-IgG chimera as previously described (10). W'fld type and mutant 
chimeras were expressed  and secreted by 293 ceils,  quantified  and tested 
for anti-selectin  mAb reactivity also as described (I0). Mutant chimeras are 
defined using the nomenclature: Kll3A is a mutant where the lysine (K) at 
position 113 is changed to an alanine (A). 
Binding of  Selectin-IgG Chimeras 
to Sialyl Lewis x and Suifatides 
Assays for binding of the different seleetin-IgG  chimeras to immobilized 
sLe  x glycolipids  or sulfatides  were performed as described (12). Briefly, 
2'3 sLe  x glycolipids, 2'6 sLe  x glycolipids, or bovine brain sulfatides (Sigma 
Immunochemicals) were dried onto microtitre wells, washed with distilled 
water, and then blocked with BSA. Biotinylated  goat anti-human IgG Fc 
and alkaline phosphatase-streptavidin  (Caltag Labs, South San Francisco, 
CA) were each diluted 1:1,000 into 293 cell supernatants containing equal 
concentrations  of wild type or mutant chimeras and allowed to form a com- 
plex before the addition to the wells.  These supernatants were then in- 
cuhated on the sLe  ~ glycolipid  or sulfatide-coated  surfaces,  followed by 
washing, addition of substtate (p-nitrophenyl  phosphate), and ~urement 
of the OD at 405 nm. 
Generation  of a P-selectin Lectin Domain Model 
A model of the P-selectin lectin domain was generated based on the crystal 
structure of the rat mannose-binding protein (MBP) (47) as previously de- 
scribed for an E-selectin lectin domain model (10). Briefly, MBP residues 
were changed to the P-selectin sequence with the sidechain conformations 
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Figure L  Staining of HL60 cells and 
neutrophils by  selectin-IgG chimeras. 
Selectin-IgG chimeras were tested by 
flow cytometry for  staining of either 
HL60 cells (,4 and C) or human neutro- 
phils (B and D) as described in Mate- 
rials and Methods. In A and B, dotted 
lines represent P-selectin-IgG staining, 
dashed  lines represent P-selectin-IgG 
staining in the presence of 10 mM EGTA, 
and solid lines represent E-selectin-IgG 
staining. Staining with no chimera (sec- 
ondary andbody only) was identical to 
E-selectin-IgG  staining for  both  cell 
types. (C) HL60 cells were treated as 
indicated (see Materials and Methods) 
and stained with P-selectin-IgG as in A. 
Results are expressed as percentage of 
cells staining positively (+SD of dupli- 
cates) based on staining with secondary 
antibody alone. (D) Human neutrophils 
before (I~) or after (r~) activation with 
PMA were stained with the indicated re- 
agents and evaluated by flow  cytometry 
as described in Materials and Methods. 
Results are shown as the linear mean 
fluorescence. 
kept similar to those of MBP where possible. Otherwise sideehaln confor- 
mations were based  on rotamer  libraries  (35),  packing,  and hydrogen- 
bonding considerations. Possible loop structures for the 11 insertions and 
two deletions in P-select.in  relative to MBP were gleaned from a search of 
crystal structures in the Protein Data Bank (3). Finally, the P-selectin model 
was subjected to repetitive cycles of energy minimization using the method 
described for E-selectin (10). 
Results 
As a starting point for evaluating the residues in P-selectin 
responsible for binding ligand, we developed a flow cytomet- 
ric assay using the P-selectin-IgG chimera to stain HL60 
cells and neutrophils. Whereas E-selectin-IgG did not bind 
HL60 cells or neutrophils in this assay, P-selectin-IgG stain- 
ing resulted in a strong fluorescence shift for both cell types 
(Fig.  1, A and B).  This binding was inhibited by EGTA, 
reflecting the calcium requirement for P-selectin's interaction 
with its ligand.  Further controls indicated that this assay 
using the P-selectin-IgG chimera reflects the published char- 
acteristics of P-selectin-ligand binding (8,  24,  31,  32,  37, 
49). In particular, treatment of HL60 cells with either tryp- 
sin or sialidase abolished staining (Fig. 1 C). Furthermore, 
P-selectin-IgG staining was inhibited by dextran sulfate and 
mannose-l-phosphate, but not by fucoidin or mannose-6- 
phosphate (Fig. 1 C). After activation of human neutrophils 
with PMA,  although surface expression of L-selectin de- 
creased and surface expression of CDll/18 increased, sur- 
face expression of the P-selectin ligand did not change (Fig. 
1 D).  In addition to neutrophils, monocytes and NK/LGL 
cells were positive when stained with P-selectin-IgG (data 
not shown), which is consistent with the expression of the 
P-selectin ligand on these cells. 
As noted above, the E-selectin-IgG chimera did not bind 
HL60 cells or neutrophils in the soluble FACS assay. We ex- 
ploited this finding to aid in mapping the region of P-selectin 
necessary for conferring this high affinity  binding. Since our 
previous study with E-selectin (10) had localized its ligand 
binding site to a region within its lectin domain, we sought 
to determine if the apparent differences in E- and P-selectin 
binding could be attributed to differences in their lectin do- 
mains.  Consequently,  we  constructed  a  chimera  (PE-1) 
which consisted of E-selectin-IgG with the E-selectin lectin 
domain replaced with the lectin domain from P-selectin. To 
see if  this chimera was folded correctly, we tested its binding 
to antibodies specific for the various domains of E-  and 
P-selectin. The PE-1 chimera reacted well with antibodies 
to the CR1 and CR2 domains of E-selectin (mAbs 9A1 and 
7El0, Table I) but not with antibodies to the lectin domain 
of E-selectin (mAbs 3B7 and 9H9, Table I). PE-1 bound to 
the blocking antibody to P-selectin (9) (AK-6, Table I), con- 
sistent with the localization of the epitope recognized by this 
mAb to the lectin domain of P-selectin. By contrast, the non- 
blocking antibodies to P-selectln, AC 1.2 and CRC 81, did 
not recognize PE-1 (Table I). This latter result is consistent 
with earlier studies which indicated a contribution of resi- 
dues within the EGF and/or CR domains of P-selectin in 
AC 1.2 binding (19).  These results are consistent with the 
PE-1 chimera being correctly folded, and indicate that at 
least part of the epitope recognized by the blocking mAb 
AK-6 is localized to the lectin domain of P-selectin. 
To determine if transferring the P-selectin lectin domain 
onto E-selectin-IgG transferred carbohydrate specificity, we 
examined binding of PE-1 to various immobilized glyco- 
lipids. This binding was compared to that seen with either 
P-selectin-IgG or E-selectin-IgG. As shown in Fig. 2, the 
PE-1 chimera appeared to closely mimic P-selectin-IgG in 
Erbe et al. P-Selectin Carbohydrate Interactions  1229 Table L PE-I Binding to Anti-selectin Antibodies 
OD 450 
rnAb Class  Clone  P-selectin-IgG  PE-1  E-selcctin-IgG 
Blocking mAb to P-sdectin 
Nonblocking mAb to P-selectin 
mAb to CR1 and CR2 of E-selectin 
mAb to lectin domain of E-selectin 
AK-6  1.3 5:0.1  1.7 5:0.1  0.0 5:0.0 
AC 1.2  2.8 5:0.1  0.1  5:0.0  0.0 5:0.0 
CRC 81  3.1  5:0.1  0.1  5:0.0  0.0 5:0.0 
9A1  0.1  5: 0.0  1.1  + 0.2  0.9 5:0.1 
7El0  0.0 5:0.0  1.6 5:0.0  1.2 5:0.2 
- 3B7  0.1  5:0.1  0.0 5:0.0  1.9 5:0.0 
9H9  0.0 5:0.0  0.0  5:0.0  2.2  5:0.1 
The P-seleetin-lgG,  E-seleetin-IgG,  and PE-1 chimeras  were  tested  for capture  by the antibodies indicated  using the ELISA  format  described  previously  (10). Re- 
sults shown are the mean optical  density +SD of duplicate determinations. 
binding to all three glycolipids tested: 2'3 sLe  ~ (Fig. 2 A), 
2'6 sLe  x (Fig. 2 B) and sulfatides (Fig. 2 C). Therefore, the 
lectin domain of P-selectin appears to be sufficient for trans- 
ferring specificity in binding to these purified glycolipids. 
We then tested the PEA chimera for cell staining to see 
if the P-selectin lectin domain could also confer the high 
affinity binding to the P-selectin ligand on HL60 cells. As 
seen in Fig. 3, the PEA chimera did bind HL60 cells. How- 
ever, the shift in fluorescence seen with PEA staining was 
not as great as that seen with P-selectin-IgG (Fig. 3). There- 
fore, although the lectin domain of P-selectin did appear 
to clearly confer HL60 ceil staining, some contribution of 
the EGF and/or CR1 domain of P-selectin may be required 
for full, high-affinity binding to these cells. Similar results 
were seen when neutrophils were stained with these three 
chimeras (data not shown). 
The above results using the PEA chimera indicated that the 
lectin domain of P-selectin contained elements responsible 
for the differences in binding of E- and P-selectin to immobi- 
lized glycolipids and cells. Therefore, we performed muta- 
genesis of the P-selectin lectin domain to further localize the 
residues responsible for the interaction of P-selectin with its 
ligand.  P-selectin mutagenesis was  focused on those sites 
which in our previous study (10) proved to be important for 
E-selectin binding to its ligand. This strategy was followed 
for two reasons. First, as mentioned above, a wealth of ex- 
perimental evidence exists indicating similarities in recogni- 
tion of sugars by E- and P-selectin. Thus, it is reasonable to 
suppose that a site important for E-selectin-mcdiated adhe- 
sion would also participate in P-selectin-mediated binding. 
The second reason derived from an experimental considera- 
tion. In the E-selectin study we were able to generate an en- 
tire panel of antibodies to serve as structural controls for the 
effects of point mutations on lectin domain structure (10). 
This  allowed the  elimination of amino  acid  substitutions 
which grossly affected folding of the E-selectin lectin do- 
main from consideration. In this study, we were limited to 
just three anti-P-selectin mAbs  (AK-6, AC  1.2,  and CRC 
81), only one of which (AK-6) was clearly shown to bind a 
determinant in the lectin domain (see above). To avoid the 
generation and analysis of mutants which do not bind ligand 
due to a gross conformational effect rather than a specific 
side chain substitution,  we restricted our analysis to only 
those mutations which had resulted in correctly folded pro- 
teins in the E-selectin analysis (10). 
As a starting point for P-selectin mutagenesis we gener- 
ated a three-dimensional model of the P-selectin lectin do- 
main  in the  same  manner that the  E-selectin model was 
generated (see Fig. 4). Comparison of the two models re- 
vealed that of the residues that appeared most important for 
E-selectin binding to 2'3 sLe  ~, three are conserved in P-selec- 
tin:  Y48,  Kill,  and Kl13.  In E-selectin, the substitutions 
Y48F, KlllA,  and Kll3A each profoundly decreased sLe  x 
binding (10).  Mutation of position 84 from R to A did not 
affect sLe  x binding by E-selectin, and mutation of position 
8 from E  to A  increased sLe  ￿9 binding by E-selectin (10). 
Fig.  5  shows the effect of complimentary substitutions at 
these positions in P-selectin on the binding of  the anti-P-selec- 
tin mAbs. Whereas none of these substitutions significantly 
affected capture by the nonblocking antibodies (AC 1.2 and 
CRC 81), each of the substitutions KSA, KII1A, and Kll3A 
partially decreased binding of the blocking antibody AK-6 
(Fig. 5). These results are consistent with the PEA chimera 
results above which localized part of the AK-6 epitope to the 
lectin domain of P-selectin. These results are also consistent 
with the relatively close alignment of these three positions 
along the same face of the P-selectin lectin domain, as pre- 
dicted by the model (Fig. 4). Furthermore, the complimen- 
tary substitutions ESA and Kll3A in E-selectin completely 
abolished binding of a number of blocking mAbs to E-selec- 
tin (10). Also like E-selectin, mutation of the residues at po- 
sitions 48 and 84 in P-selectin did not affect mAb binding 
(Fig. 5). 
Next, we evaluated these P-selectin mutants for binding to 
immobilized glycolipids and ceils (Fig. 6). Measurement of 
the  binding  of  this  panel  of  mutants  to  the  2'3  sLe  ￿9 
glycolipid indicated that P-selectin appears to use some of 
the same residues as E-selectin in binding this carbohydrate 
(Fig. 6 A). Whereas P-selectin mutants with the substitutions 
KSA and K84A still bound 2"3 sLe  ~, the mutants Y48F and 
Kll3A were completely negative. In E-selectin the mutant 
KlllA did not bind 2'3 sLe  ~ at all (10).  Here, however, the 
P-selectin mutant  KlllA  mediated partial binding  to  2'3 
sLe  ~, perhaps indicating a subtle difference in recognition 
of this sugar by E- and P-selectin. A different set of residues 
appeared to be important for binding of P-selectin to the 2'6 
form of sLe~ (Fig.  6  B).  The substitutions KSA,  KlllA, 
and K113A ablated binding, while Y48F had no effect. The 
mutant K84A also still bound 2'6 sLe  ~ (Fig.  6  B).  When 
sulfatide binding  was  evaluated,  a  third pattern  emerged 
(Fig. 6 C). Only the mutation Kll3A significantly decreased 
sulfatide binding by P-selectin. These results indicate that the 
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Figure  2.  Binding  of the  PE-1 chimera  to  immobilized  sLe  x 
glyeolipids and sulfatides. P-seleetin-IgG (o), E-selectin-IgG (~), 
or PE-1 (e) were tested at the indicated concentrations for binding 
to immobilized 2'3 sLe  x glycolipid (A), 2'6 sLe  x glycolipid (B), or 
sulfatides (C) by the ELISA procedure described in Materials and 
Methods.  Results shown represent the mean  •  SD of triplicate 
determinations. 
same  face of P-selectin appears  to participate in  binding 
these three glycolipids, with subtle differences in the resi- 
dues used to bind each sugar. 
Since a more relevant assay for measuring P-selecdn inter- 
actions with its ligand is the cell binding assay, the panel of 
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Figure  3.  Staining  of HL60 
cells with the PE-1 chimera. 
The P-selectin-IgG,  E-selcctin- 
IgG, and PEA chimeras were 
tested  for binding  to  HL60 
cells by flow cytometry as in 
Fig. 1. The percentage of  cells 
staining positively (based on 
staining  with  the  secondary 
antibody alone) with each chi- 
mera is indicated. 
HL60 cells (Fig. 5 D). Interestingly, the binding pattern seen 
with cells closely mimics that seen with the immobilized 
glycolipid 2'3  sLe  x. K8A and K84A both bound to HL60 
cells, Y48F and Kll3A did not, and KlllA bound HL60 
cells only partially. Similar reactivities were seen when neu- 
trophils  were  stained  (data  not  shown).  So,  mutation of 
residues within this pocket of P-selectin also affected binding 
to its cognate ligand on cells. Furthermore, comparison of 
the reactivity of this panel of mutants with purified glyco- 
lipids provided some potential insights into the nature of the 
carbohydrate seen by P-selectin (see Discussion). 
In E-selectin the arginine at position 97 was also important 
for sugar recognition. Mutation of this residue to alanine 
completely abolished E-selectin/2'3 sLe  x binding (10).  The 
residue at position 97 in P-selectin is a serine and the above 
results indicated that P-selectin appears to use the same re- 
gion as E-selectin in binding to its ligand.  Therefore, we 
tested if this difference in residues at position 97 could ac- 
count for the differences in ligand binding by E- and P-selec- 
tin.  Examination of the  three-dimensional models  of the 
E- and P-selectin lectin domains (Fig. 4) reveals that amino 
acid 97 falls within a loop formed by residues 94-100, which 
is an insertion in selectins relative to the mannose binding 
protein. The sequence of these two selectins is quite different 
through this stretch-YIKREKDV for E-selectin vs. YIKSP- 
SAP for P-selectin- so these loops would be expected to have 
different conformations. To test the importance of the resi- 
due at position 97 in conferring specificity to selectins, we 
made a P-selectin-IgG mutant with the 94-100 loop replaced 
with  the  corresponding  residues  from  E-selectin:  $97R, 
P98E, $99K, A100D, and P101V. We then tested this mutant 
(abbreviated REKDV) for binding to antibodies, glycolipids, 
and cells. Binding of the P-selectin-IgG REKDV mutant to 
each of the three anti-P-selectin mAbs (AK-6, AC 1.2, and 
CRC 81) was rv70% of control P-selectin-IgG binding. This 
would seem to indicate that although folding of this mutant 
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Figure 4. A model of the lectin domain of P-selectin. (Top) Shown 
is a ribbon model of the P-selectin lectin domain (right)  alongside 
a ribbon model of the E-selectin lectin domain (10) (left).  Each 
model is similarly derived from the published coordinates of  the re- 
lated type C lectin, the mannose binding protein (47) as described 
(I0 and Materials and Methods). Residues shown are colored as fol- 
lows: for P-selectin (right) K8-tight green, K84-1ight brown, S97- 
white,  and  top-to-bottom  Y48-K1t3-Klll-yellow,  for E-selectin 
(left) E8-dark green, R84-dark brown, R97-red, and top-to-bottom Y48-Kl13-Kll 1-yellow. The purple loop (residues 43-48) and the dark 
blue loop (residues 94-100) in each model denote two insertions near the proposed carbohydrate binding sites that are not found in the 
mannose binding protein. In each model the single bound calcium is depicted as a light blue ball. (Bottom) Sequence alignment of the 
human E- and P-selectin lectin domains. 
is largely correct, some subtle structural perturbations may 
be present. Accordingly, this mutant did not bind any of the 
purified  glycolipids  in  the  solid  phase  ELISA  (data  not 
shown). However, the REKDV mutant did stain HL60 cells 
in the FACS assay, although its binding was significantly less 
than that seen with control P-selectin-IgG (70% cells posi- 
five, MFI 290 for REKDV mutant vs. 97% cells positive, 
MF1416 for control P-setectin-IgG). Thus, transferring this 
loop (containing residue 97) from E- to P-selectin did not 
completely disrupt the ability of the resultant P-selectin mu- 
tant to recognize its cellular ligand.  This may indicate that 
the binding of P-selectin-IgG to its cellular ligand is of higher 
affinity than binding of P-selectin-IgG to the immobilized 
glycolipids. Also, these results would seem to imply that at 
least  some of the differences in  binding  between E-  and 
P-selectin must be due to differences outside of this region 
(see Discussion). 
Discussion 
Research on selectin-carbohydrate interactions continues to 
be hampered by a lack of detailed understanding of the sugar 
structures seen by each adhesion molecule. However, results 
from  a  number  of  approaches,  including  direct-binding 
studies, soluble carbohydrate inhibition studies, and struc- 
tural  and  conformational  analyses  of  purified  potential 
ligands,  have indicated commonalities in selectin recogni- 
tion. Many of these findings have centered around the sLe  x 
core structure. However, many of these proposed similarities 
may  be  artifacts  of forced binding  under  experimentally 
manipulated  circumstances  (see  reference 44  for discus- 
sion). In vitro assays with solid phase carbohydrate ligands 
and transfected, over-expressed selectins can be misleading 
due to the unnaturally high densities of both receptors and 
ligands (44). Furthermore, unrelated sugars can inhibit the 
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Figure 5. Reactivity of anti-P-selectin mAbs with mutant chimeras. 
P-selectin-IgG  chimeras  with  the  substitutions  indicated  were 
tested for capture by the mAbs AK-6 (m), AC 1.2 (t~), and CRC 81 
(e~) as in Table I. Results shown represent the mean + SD of dupli- 
cate determinations and are  expressed as percentage of control 
P-selectin-IgG binding. 
same lectin interaction due to structural mimicry (44). The 
flow cytometric assay used here to measure P-selectin's inter- 
actions with its cellular ligand should avoid most of these 
limitations while still being sensitive and convenient. The 
experiments presented here indicate that the measured bind- 
ing observed using the P-selectin-IgG chimera to stain cells 
accurately represents the interaction of P-selectin with its 
ligand. Studies to date have shown that P-selectin binds a sin- 
gle, possibly unique, major glycoprotein of 120 kD  (32). 
The same glycoprotein has been isolated from both neutro- 
phils and HL60 ceils (32) and the number of such binding 
sites for P-selectin is estimated at 10,000-20,000 per cell (31, 
32, 37).  sLe  x may form some component of this glycopro- 
tein ligand, and sLe  x is sufficient to confer some P-selectin 
binding.  However,  sLe  x  is  not  sufficient  to  confer  the 
saturable,  high-affinity binding characteristic of P-selectin 
adhesion (31).  Therefore, the P-selectin ligand must have 
structural features in addition to sLe" that confer specificity 
and affinity (32, 49).  The protein portion of the P-selectin 
ligand may contribute to this specificity and affinity by: (a) 
presenting the sugar in the correct configuration; (b) present- 
ing multivalent sugars to enhance binding avidity; and/or (c) 
participating  in  a  protein-protein contact with  P-selectin 
(32). In fact, a role for presentation of polyvalent ligands to 
L-selectin by the GlyCAM  1 ligand has already been pro- 
posed (27). In the assay described here, P-selectin-IgG bind- 
ing was  ablated by protease treatment of cells,  consistent 
with  a  requirement  for this  glycoprotein (24).  As  noted 
above, sialic acid is crucial to P-selectin binding and siali- 
dase treatment also  abolished binding.  Most importantly, 
removal of calcium chelation by EGTA also led to a loss of 
binding, a result that is a signature of the interactions medi- 
ated by all C-type lectins (47). A surprising finding was that 
the E-selectin-IgG chimera did not bind HL60 cells or neu- 
trophils in this fluid phase staining assay. This is despite the 
fact that the E-selectin carbohydrate ligand, sLe  x, is clearly 
expressed by these cells (33, 45). Furthermore, we (10) and 
others (41) have found that E-selectin-IgG is capable of  bind- 
ing  HL60  cells  and  neutrophils  when  the  chimera  is 
150 ' 
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Figure 6. Binding  of  P-selectin- 
IgG mutants to immobilized 
glycolipids and cells. P-selec- 
tin-IgG  chimeras  with  the 
substitutions  indicated  were 
tested for binding to immobi- 
lized 2 '3 sLe  x glycolipid (A), 
2'6  sLe  x glycolipid  (B),  or 
sulfatides (C) as in Fig. 2, and 
for staining of HL60 ceils (D) 
as in Fig. 1. 
presented on a  solid substrate,  suggesting that the lack of 
binding in the fluid phase may be due to lower affinity of 
E-selectin for its cognate cell surface ligand. Thus, E- and 
P-selectin are clearly distinct in binding to cells both as solu- 
ble Ig chimeras, as well as when they are expressed on en- 
dothelial/platelet cell surfaces. 
At least part of this difference between E- and P-selectin 
must be due to differences in their lectin domains. Transfer- 
ring the P-selectin lectin domain onto the E-selectin-IgG 
construct resulted in a molecule (PE-1) which stained cells, 
albeit at a lower intensity than P-selectin-IgG. Carbohydrate 
reactivity was completely transferred with the relevant lectin 
domain. Thus, PE-1 reacted with the purified glycolipids in 
a manner that was indistinguishable from P-selectin-IgG and 
quite distinct from E-selectin-IgG. Therefore, the lectin do- 
main of each selectin appears sufficient for determining the 
differences in reactivities with these relatively small sugars. 
This result is consistent with a study by Kansas et al.  (20) 
in which domains of L- and P-selectin were exchanged to 
show  that  PPME  and  fucoidin binding,  both  L-selectin- 
specific carbohydrate ligands, as well as the epitope defined 
by blocking mAb LAM1-3, map at least in part to the COOH- 
terminal 67 amino acid residues of the L-selectin lectin do- 
main. These authors also demonstrated that the CR domains 
are not important for conferring PPME or fucoidin specific- 
ity (20). The EGF and CR domains of selectins have clearly 
been shown to perform vital structural roles for these recep- 
tors (6, 19, 45, 46). Whether these domains in P-selectin also 
participate in making crucial contacts with its glycoprotein 
ligand cannot be answered here. However, the results of this 
study do place limitations on the nature of  any such contacts. 
Erbe et al. P-Selectin Carbohydrate Interactions  1233 First, the P-selectin-IgG chimera used here only contains 
the lectin, EGF, and CR1 domains of P-selectin (12). Thus, 
CR2-CR9 must not form necessary contacts for the high 
affinity  binding between P-selectin and its ligand and it is in- 
teresting to note that mouse P-selectin lacks the CR2 domain 
(48).  In addition, because the PE-1 chimera did bind cells, 
any potential protein-protein contact sites may map to the 
lectin domain of P-selectin. The difference in staining be- 
tween PEA and P-selectin-IgG might reflect subtle confor- 
mational effects of the P- or E-selectin EGF domains inter- 
acting  with  the  common  lectin  domain.  However,  it  is 
important to stress that protein-protein contacts mediated by 
the EGF or CR1 domains cannot be ruled out. 
Two recent studies have identified regions of the P-selectin 
lectin domain that may be important for cell adhesion (14, 
15). Geng and co-workers showed that a mAb capable of in- 
hibiting neutrophil binding to P-selectin mapped to residues 
19-34 of this molecule, and that a peptide corresponding to 
this stretch also inhibited neutrophil binding to P-selectin 
(14). This group described other peptides from the lectin do- 
main of P-selectin (corresponding to residues 23-30, 54-63, 
and  70-79)  which  blocked  P-selectin-mediated adhesion 
(15). In the model of P-selectin, these residues fall on the op- 
posite side of the lectin domain from the site that we have 
identified  as important for selectin-carbohydrate binding and 
cell adhesion (see Fig. 4  and reference 10).  The residues 
characterized by Geng and coworkers may represent a sec- 
ond  site  in  P-selectin  which  may bind  the  carbohydrate 
and/or protein component of its ligand. In light of this, it is 
important to remember that the results with the REKDV mu- 
tant indicated that not all of the differences in specificity be- 
tween E-  and P-selectin can be  explained by the  region 
identified in this study. Therefore, the possible co-operation 
of this site with those described by Geng et al. (14,  15) in 
conferring  P-selectin  binding  specificity  warrants  explo- 
ration. 
The results presented here establish that the site previ- 
ously identified as crucial for E-selectin binding to 2'3 sLe  ~ 
is also crucial to P-selectin binding to this ligand. Mutations 
in two of the conserved residues within this site, Y48 and 
K113, completely abolished 2'3 sLe  ￿9 binding and cell adhe- 
sion by both E- and P-selectin. The anti-P-selectin blocking 
mAb AK-6 mapped to this same site, as did all of the anti- 
E-selectin  blocking  mAbs  (10). Furthermore,  Mel-14,  a 
mAb that blocks L-selectin-mediated adhesion in vitro and 
in vivo, maps to this region (6,  10). The fact that adhesion 
blocking mAbs to all three selectins bind to residues within 
this site emphasizes its importance to the adhesive functions 
of these proteins. 
By comparing the binding of the panel of P-selectin mu- 
tants to 2'3 sLeL 2'6 sLeL and sulfatides with their ability 
to bind cells, some insight as to the nature of the carbohy- 
drate component of the P-selectin ligand can be gained. As 
noted above, one study has shown that E- and P-selectin have 
related but distinct carbohydrate specificities (24).  For ex- 
ample, these authors found that the interaction of E-selectin 
with the sl_~ component of the P-seleetin ligand precludes 
P-selectin binding (24).  Using a  2'6  sialyl-specific lectin 
to block  P-selectin binding,  they also  proposed  that the 
P-selectin ligand may contain a bidentate carbohydrate struc- 
ture with one ann containing 2'3 sLe  x and the other a ter- 
minal sialyl-2'6 beta Gal (13, 24). However, our results with 
the P-selectin mutants would seem to question a role for 2'6- 
1inked  sialic acid in  cell adhesion.  The mutant KSA did 
not bind the 2'6  form of sLe  x at all,  but still bound the 
P-selectin ligand on cells. Furthermore, the Y48F mutant did 
not bind cells at all, but still bound 2'6 sLe  ~. Consequently, 
2'6  sLe  x binding  did  not  correlate  with  ligand  binding. 
However,  the binding to 2'6 sLe  ￿9 in the solid phase assays 
used here is weak compared to 2'3 sLe  ￿9 and sulfatide bind- 
ing,  so caution is warranted in interpreting these results. 
Thus, it is conceivable that presentation of the 2'6 sialylated 
carbohydrate to P-selectin provides a critical parameter of 
ligand recognition that is not replicated in our solid phase 
assay (27). 
A second binding activity of P-selectin whose biological 
relevance has been recently questioned is its interaction with 
sulfatides. Sulfatide binding by P-selectin is probably not 
relevant in vivo due to the observation that this interaction 
would be protease resistant, and that cells expressing sulfa- 
tides  (erythrocytes and platelets)  do not necessarily bind 
P-selectin (32). Also, sulfatide binding by the P-selectin mu- 
tants studied here did not correlate with cell binding. For ex- 
ample, mutant Y48F bound sulfatides well but did not adhere 
to cells at all. Cell binding was only correlated with binding 
to 2'3 sLe  x. Each mutant which bound 2'3 sLe  ~ bound cells 
(KSA and K84A), while those which did not bind 2'3 sLe  x 
(Y48F  and  Kll3A)  did  not bind  cells,  and  one  mutant 
(KlllA) showed partial binding to both 2'3 sLe  x and cells. 
This is interesting given a recent study demonstrating that 
expression of 2'3 sLe  ~ correlated with a cell's ability to bind 
activated platelets via  P-selectin (9),  and it is  consistent 
with the mAb and carbohydrate blocking studies of Polley et 
al. (34). 
Although one  cannot rule  out  the  involvement of  2'6-1inked 
sialic  acid  or sulfatides  in P-selectin's  interactions  with its 
ligand,  the  data  presented  here  clearly  questions  the  role  they 
may play.  Specificity  of binding between E- and P-selectin 
may derive from the manner in which 2'3 sLe  ~  is  presented 
(i.e.,  glycolipid  vs. glycoprotein).  However, it must be al- 
lowed that  2'3 sLc  x  may not be the naturally  occurring car- 
bohydrate ligand recognized by either selectin, and that these 
differences in selectin binding could be accounted for by sub- 
fie changes in the saccharide itself (44). Sulfatides, as well 
as the sulfated glycans heparin, fucoidin, and dextran sul- 
fate, may inhibit P-selectin function by mimicking its li- 
gand (32).  sLeL sulfated glycans, and sulfatides all have a 
negative charge which may play a role in the interaction of 
P-selectin with its ligand (9, 10) and these sugars may inhibit 
selectin-mediated adhesion by binding to a common site (for 
example, at Kl13) which is important for P-selectin-ligand 
interactions. 
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